Clinical Trial Update: Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of pemetrexed plus paclitaxel in recurrent or advanced thyroid cancer; the document notes the trial status as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Taxol (paclitaxel)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Thyroid Cancer | Phase 2 | Status: UNKNOWN